147 related articles for article (PubMed ID: 16769717)
1. British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.
Rudd RM; Prescott RJ; Chalmers JC; Johnston ID;
Thorax; 2007 Jan; 62(1):62-6. PubMed ID: 16769717
[TBL] [Abstract][Full Text] [Related]
2. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids.
Pereira CA; Malheiros T; Coletta EM; Ferreira RG; Rubin AS; Otta JS; Rocha NS
Respir Med; 2006 Feb; 100(2):340-7. PubMed ID: 16002271
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
4. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
[TBL] [Abstract][Full Text] [Related]
5. High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Demedts M; Behr J; Buhl R; Costabel U; Dekhuijzen R; Jansen HM; MacNee W; Thomeer M; Wallaert B; Laurent F; Nicholson AG; Verbeken EK; Verschakelen J; Flower CD; Capron F; Petruzzelli S; De Vuyst P; van den Bosch JM; Rodriguez-Becerra E; Corvasce G; Lankhorst I; Sardina M; Montanari M;
N Engl J Med; 2005 Nov; 353(21):2229-42. PubMed ID: 16306520
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
[TBL] [Abstract][Full Text] [Related]
7. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
[TBL] [Abstract][Full Text] [Related]
8. Response to steroid therapy in patients of idiopathic pulmonary fibrosis: a retrospective analysis.
Behera D; Gupta D; Jindal SK
Indian J Chest Dis Allied Sci; 1998; 40(3):163-9. PubMed ID: 9919835
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.
Plastiras SC; Karadimitrakis SP; Ziakas PD; Vlachoyiannopoulos PG; Moutsopoulos HM; Tzelepis GE
Arthritis Rheum; 2006 Aug; 55(4):598-602. PubMed ID: 16874782
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of idiopathic fibrosing alveolitis. Therapeutic experiences with azathioprine-prednisolone and D-penicillamine-prednisolone combination therapy].
Cegla UH
Schweiz Med Wochenschr; 1977 Feb; 107(6):184-7. PubMed ID: 834991
[TBL] [Abstract][Full Text] [Related]
11. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
Hubbard R; Johnston I; Britton J
Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
[TBL] [Abstract][Full Text] [Related]
12. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.
Johnston ID; Prescott RJ; Chalmers JC; Rudd RM
Thorax; 1997 Jan; 52(1):38-44. PubMed ID: 9039238
[TBL] [Abstract][Full Text] [Related]
13. Digital vasculitis in patients with cryptogenic fibrosing alveolitis.
Hodson ME; Haslam PL; Spiro SG; Turner-Warwick M
Br J Dis Chest; 1984 Apr; 78(2):140-8. PubMed ID: 6722017
[TBL] [Abstract][Full Text] [Related]
14. Cryptogenic fibrosing alveolitis and lung cancer: the BTS study.
Harris JM; Johnston ID; Rudd R; Taylor AJ; Cullinan P
Thorax; 2010 Jan; 65(1):70-6. PubMed ID: 19996344
[TBL] [Abstract][Full Text] [Related]
15. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function in children treated for rhabdomyosarcoma.
Kaplan E; Sklar C; Wilmott R; Michaels S; Ghavimi F
Med Pediatr Oncol; 1996 Aug; 27(2):79-84. PubMed ID: 8649324
[TBL] [Abstract][Full Text] [Related]
17. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.
Al-Chalabi T; Underhill JA; Portmann BC; McFarlane IG; Heneghan MA
J Hepatol; 2008 Jan; 48(1):140-7. PubMed ID: 18023911
[TBL] [Abstract][Full Text] [Related]
18. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis.
Colaci M; Sebastiani M; Giuggioli D; Manfredi A; Spagnolo P; Luppi F; Richeldi L; Ferri C
Scand J Rheumatol; 2010 Mar; 39(2):155-9. PubMed ID: 20059446
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic lung fibrosis].
Schmid-Zumstein A; Bernheim R; Medici TC
Schweiz Med Wochenschr; 1988 Jun; 118(25):979-85. PubMed ID: 3045952
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis.
Jeon K; Chung MP; Lee KS; Chung MJ; Han J; Koh WJ; Suh GY; Kim H; Kwon OJ
Respir Med; 2006 Mar; 100(3):451-7. PubMed ID: 16084076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
